Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN06
- Pharmacological subgroupN06A
- Chemical subgroupN06AB
- Chemical substanceN06AB03Fluoxetine
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 33 medicines
FDA · 14 medicines
AIFA · 13 medicines
SFDA · 13 medicines · Historical list
CBG-MEB · 9 medicines
HSA · 6 medicines
MS · 5 medicines · Historical list
PHARMAC · 2 medicines
ALIMS · 2 medicines
EMA · 1 medicine · Historical list
Show all 1HALMED · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
33 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| FLUOXETINA VIR 20 mg CAPSULAS DURAS EFG | Spain | 22,36 mg | cápsula dura | Marketed | Industria Quimica Y Farmaceutica Vir S.A. |
| FLUOXETINA CINFA 20 mg CAPSULAS DURAS EFG | Spain | 22,36 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| FLUOXETINA ALMUS 20 mg CAPSULAS DURAS EFG | Spain | 22,4 mg | cápsula dura | Marketed | Almus Farmaceutica S.A.U. |
| FLUOXETINA NORMON 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| Fluoxetina Viatris 20 MG Capsulas Duras Efg | Spain | 22,36 mg | cápsula dura | Marketed | Viatris Limited |
| Fluoxetina Aurovitas 20 MG Capsulas Duras Efg | Spain | 22,357 mg | cápsula dura | Marketed | Aurovitas Spain, S.A.U. |
| FLUOXETINA NORMON 20 mg/5 ml SOLUCION ORAL EFG | Spain | 20 mg | solución oral | Marketed | Laboratorios Normon S.A. |
| FLUOXETINA KERN PHARMA 20 mg CAPSULAS DURAS EFG | Spain | 22,36 mg | cápsula dura | Marketed | Kern Pharma S.L. |
| FLUOXETINA PHARMA COMBIX 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Marketed | Laboratorios Combix S.L.U. |
| FLUOXETINA TEVA-RIMAFAR 20 mg CAPSULAS DURAS EFG | Spain | 22,4 mg | cápsula dura | Marketed | Teva Pharma S.L.U. |
| FLUOXETINA CINFA 20 mg COMPRIMIDOS DISPERSABLES EFG | Spain | 22,36 mg | comprimido dispersable | Marketed | Laboratorios Cinfa S.A. |
| Fluoxetina Viatris 20 MG Comprimidos Dispersables Efg | Spain | 20,00 mg | comprimido dispersable | Marketed | Viatris Pharmaceuticals S.L. |
| FLUOXETINA TEVA-RATIOPHARM 20 mg COMPRIMIDOS DISPERSABLES EFG | Spain | 20 mg | comprimido dispersable | Marketed | Teva Gmbh |
| LURAMON 20 mg CAPSULAS DURAS | Spain | 20 mg | cápsula dura | Marketed | Industria Quimica Y Farmaceutica Vir S.A. |
| FLUOXETINA RATIO 20 mg CAPSULAS EFG | Spain | 22,36 mg | cápsula dura | Withdrawn | Ratiopharm Espana S.A. |
| FLUOXETINA MABO 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Withdrawn | Mabo Farma S.A. |
| FLUOXETINA DAVUR 20 mg CAPSULAS DURAS EFG | Spain | 22,4 mg | cápsula dura | Withdrawn | Teva Pharma S.L.U. |
| FLUOXETINA BENEL 20 mg CAPSULAS DURAS EFG | Spain | 20,0 mg | cápsula dura | Suspended | Farmalider S.A. |
| Fluoxetina Combix 20 MG Capsulas Duras Efg | Spain | 22,4 mg | cápsula dura | Withdrawn | Laboratorios Combix S.L.U. |
| FLUOXETINA COMBIX 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Withdrawn | Laboratorios Combix S.L.U. |
| FLUOXETINA STADA 20 mg CAPSULAS DURAS EFG | Spain | 22,36 mg | cápsula dura | Suspended | Laboratorio Stada S.L. |
| FLUOXETINA ARISTO 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Withdrawn | Aristo Pharma Iberia S.L. |
| FLUOXETINA TARBIS 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Suspended | Tarbis Farma S.L. |
| FLUOXETINA DERMOGEN 20 mg CAPSULAS DURAS EFG | Spain | 22,36 mg | cápsula dura | Suspended | Dermogen-Farma S.A. |
| FLUOXETINA QUALIGEN 20 mg CAPSULAS DURAS EFG | Spain | 20 mg | cápsula dura | Withdrawn | Neuraxpharm Spain S.L. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.